Provided by Tiger Fintech (Singapore) Pte. Ltd.

DELCATH SYSTEMS INC

16.38
-0.4900-2.90%
Post-market: 16.470.0900+0.55%19:52 EDT
Volume:391.15K
Turnover:6.51M
Market Cap:570.45M
PE:-35.69
High:17.35
Open:16.94
Low:16.24
Close:16.87
Loading ...

Delcath Systems Reports Fourth Quarter and Full Year 2024 Results

Business Wire
·
06 Mar

Delcath Systems Inc expected to post a loss of 2 cents a share - Earnings Preview

Reuters
·
04 Mar

BRIEF-Delcath Systems Announces Update To National Comprehensive Cancer Network Clinical Practice Guidelines

Reuters
·
14 Feb

Delcath Systems Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines for the Treatment of Metastatic Uveal Melanoma

THOMSON REUTERS
·
14 Feb

Delcath Systems: Updated Nccn Guidelines Include Hepzato Kit as Category 2a Treatment for Patients With Hepatic-Dominant Uveal Melanoma

THOMSON REUTERS
·
14 Feb

Delcath Systems Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines for the Treatment of Metastatic Uveal Melanoma

Business Wire
·
14 Feb

Delcath Systems to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Business Wire
·
29 Jan

retail investors who own 58% along with institutions invested in Delcath Systems, Inc. (NASDAQ:DCTH) saw increase in their holdings value last week

Simply Wall St.
·
26 Jan

Craig-Hallum Reaffirms Their Buy Rating on Delcath Systems (DCTH)

TIPRANKS
·
14 Jan

Delcath Systems Price Target Maintained With a $22.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Jan

Delcath Systems Inc - Q4 Revenue Expected to Be $15.1 Mln, Full Year $37.2 Mln

THOMSON REUTERS
·
13 Jan

Press Release: Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results

Dow Jones
·
13 Jan

BRIEF-Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
04 Jan

Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
04 Jan

Delcath Systems Announces Additional $16.3 Million in Funding From Series E and E1 Warrant Exercises

THOMSON REUTERS
·
30 Dec 2024

Delcath Systems Announces Additional $16.3 Million in Funding From Series E and E1 Warrant Exercises

Business Wire
·
30 Dec 2024

3 US Growth Companies To Watch With Up To 32% Insider Ownership

Simply Wall St.
·
30 Dec 2024

Analysts Expect Breakeven For Delcath Systems, Inc. (NASDAQ:DCTH) Before Long

Simply Wall St.
·
29 Dec 2024

Delcath Systems (DCTH) Gets a Buy from Craig-Hallum

TIPRANKS
·
05 Dec 2024

Delcath Gets FDA Clearance for Phase 2 Liver Cancer Trial

MT Newswires Live
·
02 Dec 2024